Profil
Alexander Nolte worked as Director-International Accounting at Aegerion Pharmaceuticals, Inc. from 2013 to 2015.
He then worked as Chief Accounting Officer & Vice President at Syndax Pharmaceuticals, Inc. from 2017 to 2023.
In 2023, he became the Chief Financial Officer, Treasurer & CAO at Oncorus, Inc. Mr. Nolte received an undergraduate degree from The Hague University of Applied Sciences.
Anciens postes connus de Alexander Nolte
| Sociétés | Poste | Fin |
|---|---|---|
| ONCORUS, INC. | Directeur Financier/CFO | 04/08/2023 |
| SYNDAX PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/06/2022 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2015 |
Formation de Alexander Nolte
| The Hague University of Applied Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| ONCORUS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
